Supplementary Figure 3 from Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multiomics Platform

作者：Frank A. Sinicrope, Nalin Sharma, Md Mohiuddin, Bahar Saberzadeh-Ardestani, Rondell P. Graham, Jason T. Lewis, Bailiang Li, Charles W. Abbott, Sean Michael Boyle · 年份：2026 · DOI：10.1158/1078-0432.33014417 · 研究领域：Medicine、Oncology、Internal medicine、Cancer research、Immunology

<p>HLA loss of heterogeneity (HLA LOH) and tumor neoantigen burden in relationship to clinical outcome variables in dMMR CRC.</p>